BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

989 related articles for article (PubMed ID: 11751372)

  • 21. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker.
    Lee WH; Isaacs WB; Bova GS; Nelson WG
    Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):443-50. PubMed ID: 9184779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
    Ellinger J; Haan K; Heukamp LC; Kahl P; Büttner R; Müller SC; von Ruecker A; Bastian PJ
    Prostate; 2008 Jan; 68(1):42-9. PubMed ID: 18004747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation.
    Cairns P; Esteller M; Herman JG; Schoenberg M; Jeronimo C; Sanchez-Cespedes M; Chow NH; Grasso M; Wu L; Westra WB; Sidransky D
    Clin Cancer Res; 2001 Sep; 7(9):2727-30. PubMed ID: 11555585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas.
    Tchou JC; Lin X; Freije D; Isaacs WB; Brooks JD; Rashid A; De Marzo AM; Kanai Y; Hirohashi S; Nelson WG
    Int J Oncol; 2000 Apr; 16(4):663-76. PubMed ID: 10717233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silencing and CpG island methylation of GSTP1 is rare in ordinary gastric carcinomas but common in Epstein-Barr virus-associated gastric carcinomas.
    Kim J; Lee HS; Bae SI; Lee YM; Kim WH
    Anticancer Res; 2005; 25(6B):4013-9. PubMed ID: 16309193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia.
    Esteller M; Corn PG; Urena JM; Gabrielson E; Baylin SB; Herman JG
    Cancer Res; 1998 Oct; 58(20):4515-8. PubMed ID: 9788592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of real-time quantitative polymerase chain reaction to detect hypermethylation of the CpG islands in the promoter region flanking the GSTP1 gene to diagnose prostate carcinoma.
    Chu DC; Chuang CK; Fu JB; Huang HS; Tseng CP; Sun CF
    J Urol; 2002 Apr; 167(4):1854-8. PubMed ID: 11912447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preneoplastic prostate lesions: an opportunity for prostate cancer prevention.
    Nelson WG; De Marzo AM; Deweese TL; Lin X; Brooks JD; Putzi MJ; Nelson CP; Groopman JD; Kensler TW
    Ann N Y Acad Sci; 2001 Dec; 952():135-44. PubMed ID: 11795433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversible epigenetic fingerprint-mediated glutathione-S-transferase P1 gene silencing in human leukemia cell lines.
    Karius T; Schnekenburger M; Ghelfi J; Walter J; Dicato M; Diederich M
    Biochem Pharmacol; 2011 Jun; 81(11):1329-42. PubMed ID: 21453686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance.
    Reibenwein J; Pils D; Horak P; Tomicek B; Goldner G; Worel N; Elandt K; Krainer M
    Prostate; 2007 Mar; 67(4):427-32. PubMed ID: 17192910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors.
    Toyota M; Shen L; Ohe-Toyota M; Hamilton SR; Sinicrope FA; Issa JP
    Cancer Res; 2000 Aug; 60(15):4044-8. PubMed ID: 10945606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutathione-S-transferase pi 1(GSTP1) gene silencing in prostate cancer cells is reversed by the histone deacetylase inhibitor depsipeptide.
    Hauptstock V; Kuriakose S; Schmidt D; Düster R; Müller SC; von Ruecker A; Ellinger J
    Biochem Biophys Res Commun; 2011 Sep; 412(4):606-11. PubMed ID: 21855532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
    Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
    Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
    Bastian PJ; Ellinger J; Schmidt D; Wernert N; Wellmann A; Müller SC; von Rücker A
    Eur J Med Res; 2004 Nov; 9(11):523-7. PubMed ID: 15649863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection.
    Nakayama M; Bennett CJ; Hicks JL; Epstein JI; Platz EA; Nelson WG; De Marzo AM
    Am J Pathol; 2003 Sep; 163(3):923-33. PubMed ID: 12937133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
    Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
    Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
    Esteller M
    Oncogene; 2002 Aug; 21(35):5427-40. PubMed ID: 12154405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells.
    Jarrard DF; Kinoshita H; Shi Y; Sandefur C; Hoff D; Meisner LF; Chang C; Herman JG; Isaacs WB; Nassif N
    Cancer Res; 1998 Dec; 58(23):5310-4. PubMed ID: 9850055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.